Imaging in patients with cardiovascular implantable electronic devices: part 2—imaging after device implantation. A clinical consensus statement of the European Association of Cardiovascular Imaging (EACVI) and the European Heart Rhythm Association (EHRA) of the ESC
Ivan Stanković, Jens‐Uwe Voigt, Haran Burri, Denisa Muraru, Leyla Elif Sade, Kristina H. Haugaa, Joost Lumens, Mauro Biffi, Jean‐Nicolas Dacher, Nina Ajmone Marsan, Elise Bakelants, Charlotte Manisty, Marc R. Dweck, Otto A. Smiseth, Erwan Donal, Daniele Andreini, Magnus Bäck, Philippe B. Bertrand, Niall Keenan, Danilo Neglia, by the 2020–2022 EACVI President:, Bernard Cosyns
Abstract
Cardiac implantable electronic devices (CIEDs) improve quality of life and prolong survival, but there are additional considerations for cardiovascular imaging after implantation-both for standard indications and for diagnosing and guiding management of device-related complications. This clinical consensus statement (part 2) from the European Association of Cardiovascular Imaging, in collaboration with the European Heart Rhythm Association, provides comprehensive, up-to-date, and evidence-based guidance to cardiologists, cardiac imagers, and pacing specialists regarding the use of imaging in patients after implantation of conventional pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy (CRT) devices. The document summarizes the existing evidence regarding the role and optimal use of various cardiac imaging modalities in patients with suspected CIED-related complications and also discusses CRT optimization, the safety of magnetic resonance imaging in CIED carriers, and describes the role of chest radiography in assessing CIED type, position, and complications. The role of imaging before and during CIED implantation is discussed in a companion document (part 1).